Synopsys Announces Availability of DesignWare SATA PHY IP in SMIC 130nm Process Technology

Synopsys, Inc., a world leader in software and IP for semiconductor design and manufacturing, today announced the immediate availability of the silicon-proven DesignWare(R) SATA PHY IP for SMIC's popular 130 nanometer (nm) process technology, for use in host and device applications such as mobile internet devices, set-top boxes, solid state drives and optical disk drives. As a leading provider of connectivity IP, Synopsys has expanded the SATA IP portfolio by introducing the SATA PHY IP for the SMIC 130-nm technology, therefore enabling a comprehensive SATA solution, which also includes the AHCI host and device digital controllers as well as verification IP. Accessing all the IP from one provider allows designers to lower the risk and cost of integrating SATA interfaces into their high-performance system-on-chip (SoC) designs.

The DesignWare SATA PHY IP substantially exceeds the SATA electrical specification in areas such as jitter, margin and receive sensitivity, thus delivering a robust design without sacrificing performance. The advanced built-in diagnostic capabilities provide customers with an on-chip sampling scope for quick debug of the PHY without the need for expensive test equipment. The PHY also comes with ATE test vectors which enable at-speed production testing of the PHY. Additionally, the DesignWare SATA PHY IP relies exclusively on standard digital CMOS process technology and does not require special process options, which results in significant manufacturing cost reduction and ease of integration into a SoC.

"As an established IP supplier, Synopsys provides chip designers with high-quality IP solutions that offer a wealth of advanced features, combined with excellent technical support," said Paul OuYang, vice president of SMIC marketing and sales. "Having Synopsys' silicon-proven IP available in the SMIC 130-nm manufacturing process technology enables designers to quickly achieve time-to-market goals for their high-performance storage applications and then ramp into volume production."

"With the release of the DesignWare SATA PHY IP designed for SMIC 130-nm technology, Synopsys continues to provide designers with the IP they need in the required foundry process," said John Koeter, vice president of marketing for the Solutions Group at Synopsys. "Synopsys is addressing key concerns that our customers are facing today by characterizing the PHY to help ensure it meets and exceeds the SATA specification and passes SATA-IO compliance, thereby providing customers confidence that our PHY is fully interoperable with other SATA products."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Synopsys, Inc.. (2019, February 15). Synopsys Announces Availability of DesignWare SATA PHY IP in SMIC 130nm Process Technology. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=8432.

  • MLA

    Synopsys, Inc.. "Synopsys Announces Availability of DesignWare SATA PHY IP in SMIC 130nm Process Technology". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=8432>.

  • Chicago

    Synopsys, Inc.. "Synopsys Announces Availability of DesignWare SATA PHY IP in SMIC 130nm Process Technology". AZoNano. https://www.azonano.com/news.aspx?newsID=8432. (accessed November 21, 2024).

  • Harvard

    Synopsys, Inc.. 2019. Synopsys Announces Availability of DesignWare SATA PHY IP in SMIC 130nm Process Technology. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=8432.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.